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Malassezia furfur sepsis in a cancer patient
El˝bieta Ochman, Barbara Podsiad∏o, Hanna Po∏owniak-Pracka,
El˝bieta Hagmajer, Piotr Sowiƒski
We present the case of a patient with cancer of the cardia treated surgically at The Maria Sklodowska-Curie Memorial
Cancer Centre and Institute of Oncology in Warsaw. Surgery comprised total gastrectomy, resection of the inferior part of
oesophagus, the spleen and neighbouring lymph nodes and removal of the serosa covering the transverse mesocolon and the
pancreas. Beginning with postoperative day 3 numerous, consecutive complications were observed, necessitating two re-
operations. The patient’s emaciation related to both the primary disease, and to surgery, required parenteral nutrition and lipid
supplementation. In the course of treatment we observed bacterial infection and Malassezia furfur fungemia. Fungal cultures
were performed in the BACTEC 9050 system (Becton-Dickinson). In direct culture preparations of the Bactec Mycosis
IC/F medium, we observed clusters of yeast cells, some budding. The fungi failed to grow after 48hrs of incubation in the
Sabouraud and in 5% sheep blood agar media. We obtained microscopic colonies resembling the growth of bacteria after as
long as 5 days of fungal culture in the Sabouraud medium. Since the yeast cells observed in direct cultures morphologically
resembled fungi of the Malassezia genus, at the same time the culture was inoculated on the Sabouraud medium supplemented
with sterile olive oil with a small addition of Tween 80. After 48 hrs of incubation, we observed the growth of multiple yeast
colonies. They were identified according to the key as Malassezia furfur. Initial treatment consisted of eliminating lipids
from parenteral nutrition and the administration of fluconazole.
Posocznica wywo∏ana przez Malassezia furfur u chorego z nowotworem
Przedstawiono przypadek chorego z rakiem wpustu, leczonego chirurgicznie w Centrum Onkologii w Warszawie. Zabieg
chirurgiczny obejmowa∏ ca∏kowite wyci´cie ˝o∏àdka z dolnym odcinkiem prze∏yku, usuni´cie Êledziony, regionalnych w´z∏ów
ch∏onnych, usuni´cie b∏ony surowiczej, pokrywajàcej krezk´ poprzecznicy i trzustk´. W 3 dobie dosz∏o do licznych, nast´pu-
jàcych po sobie, komplikacji, w wyniku czego pacjent by∏ dwukrotnie reoperowany. Zwiàzane z chorobà zasadniczà wynisz-
czenie organizmu pacjenta oraz os∏abienie zabiegami chirurgicznymi wymaga∏o zastosowania ˝ywienia pozajelitowego i su-
plementacji t∏uszczowej. W wyniku komplikacji pooperacyjnych pojawi∏y si´ zaka˝enia bakteryjne oraz fungemia, wywo∏ana
przez Malassezia furfur. Hodowl´ grzyba uzyskano w systemie BACTEC 9050 firmy Becton-Dickinson. W preparatach bez-
poÊrednich z hodowli na pod∏o˝u Bactec Mycosis IC/F stwierdzono zlepy komórek dro˝d˝opodobnych, z których nieliczne pàcz-
kowa∏y. Grzyby nie wyrasta∏y po 48 godzinach inkubacji na pod∏o˝ach: Sabourauda i agarze z 5% krwi baraniej. Dopiero po
5 dniach hodowli uzyskano wzrost grzybów na pod∏o˝u Sabourauda, w postaci mikroskopijnych kolonii przypominajàcych
wzrost bakterii. Poniewa˝ komórki grzybów dro˝d˝opodobnych, widoczne w preparatach bezpoÊrednich z hodowli, pod
wzgl´dem morfologicznym przypomina∏y grzyby z rodzaju Malassezia, równoczeÊnie wykonano posiew na pod∏o˝e Sabourau-
da, pokryte warstwà sterylnej oliwy z oliwek z niewielkim dodatkiem Tween 80. Po 48 godzinach inkubacji uzyskano wzrost licz-
nych kolonii dro˝d˝aków, które w oparciu o klucz zidentyfikowano jako gatunek Malassezia furfur. Pierwszym elementem le-
czenia by∏a eliminacja substancji t∏uszczowych z ˝ywienia pozajelitowego oraz w∏àczenie flukonazolu.
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Yeasts of the Malassezia genus (synonym: Pityrosporum)
are saprotrophs of the healthy skin in people and animals
[1, 2]. They usually inhabit areas in the vicinity of
sebaceous glands as they need fatty substances to grow
(lipophilic organisms) [1]. The Malassezia genus comprises
such species as M. furfur (Pityrosporum ovale, P. orbi-
culare), M. pachydermatis and recently isolated: M. obtusa,
M. restricta, M. slooffiae, M. globosa [3, 4]. These orga-
nisms can also cause superficial mycosis and, in some
cases, systemic mycosis [5-8]. The best-known species is
M. furfur. It may cause pityriasis versicolor with mildly
exfoliating, discoloured or pigmented patches on the skin,
folliculitis or seborrhoea [9]. In immunocompromised
patients, emaciated adults and infants with low birth
weight, who receive parenteral nutrition with lipids [3, 9,
8], M. furfur and M. pachydermatis [10] can cause fun-
gemia. It is manifested by fever which does not subside
after broad-spectrum antibiotics, interstitial pneumonia,
thrombocytopenia and heart damage. Sometimes one
may observe fungal clots surrounding the catheter tip
and/or pericardial excrescence of fungal mass [11]. The
source of infection are usually fungi found on the skin
which initially colonise the deep vein catheter used for
parenteral nutrition and are then transferred to blood-
stream [8, 12, 13]. They can also be transferred on the
hands of medical staff, and their source may be the skin of
pets (cats, dogs) [6]. In this work we present a case of
fungemia caused by fungi of the Malassezia furfur species
– the first such report in Polish medical literature – in
a patient receiving parenteral lipid supplementation.
Case Report
A 45 -year-old man with cancer of the cardia was qualified
for primary surgical treatment at The Maria Sklodowska-
Curie Memorial Cancer Centre and Institute of Oncology
in Warsaw.
On admission the patient presented with weight loss
(about 5 kg over the previous 3 months) and dysphagia –
stage II acc. to the WHO scale. Additional tests showed
the traits of mild protein-energy malnutrition.
In the preoperative period, two units of blood were
collected for autotransfusion, a central line was inserted
through the right internal jugular vein and parenteral
nutrition (amino-acids, carbohydrates, lipids) was
administered for 7 days without any complications. The
supply of non-protein calories in the form of carbo-
hydrates and lipids was set at 1600 kcal/d. Lipids were
withdrawn 24 hours before surgery.
Surgery consisted of total gastrectomy, resection of
the inferior part of oesophagus, the spleen and neigh-
bouring lymph nodes and removal of the serosa covering
the transverse mesocolon and of the pancreas. The
continuity of alimentary tract was reconstructed with the
intestinal interposition of the first loop of the jejunum; in
the posterior lower mediastinum the oesophageal stump
was anastomosed with the antimesenteric side of the
intestine; the distal end of the intestinal interposition was
anastomosed with the duodenal stump; the continuity of
jejunum was reconstructed; a nutritional jejunostomy
tube, chest drainage, a nasogastric tube in the stomach
and a Penrose drain were placed.
The operation was performed by left thoraco-
laparotomy in the oblique position, with general endo-
tracheal and continuous epidural anaesthesia. At the
chest stage of surgery, ventilation was maintained with
the exclusion of the left lung. The course of surgery and
anaesthesia was uneventful.
After the operation the patient was admitted to the
Intensive Care Unit (ICU) in good general condition.
During the postoperative period, beginning with the third
postoperative day, there occurred numerous, consecutive
complications: perforation of the large intestine, peri-
tonitis and an anastomotic leak, followed by dehiscense of
the anastomosis of the oesophagal stump with the
intestine in the posterior lower mediastinum causing, in
turn, mediastinitis, pyothorax, small intestinal fistula,
sepsis and multi organ failure (respiratory failure with
the Acute Respiratory Distress Syndrome – ARDS,
circulatory collapse, kidney and liver failure, disseminated
intravascular coagulation – DIC and gastrointestinal
bleeding).
During his stay in the ICU the patient was re-
operated twice, required mechanical lung ventilation and
respiratory assistance for 24 days (on day 7 after endo-
tracheal intubation tracheostomy was performed); for
many days, due to the symptoms of circulatory failure,
intravenous catecholamines (dopamine, dobutamine,
noradrenaline) were administered. Due to coagulation
abnormalities the patient required the administration
heparin, antithrombin and trascolan, as indicated by
laboratory results. He also received numerous trans-
fusions of blood derivatives (packed red blood cells,
packed platelets, fresh frozen plasma).
Bacause the patient had prolonged infection caused
by mixed, variable gram-positive and gram-negative flora,
continual antibiotic treatment was conducted for several
weeks, based on the results of cultures obtained systema-
tically from many sites (bronchoalveolar lavage – BAL,
abdominal cavity, pleural cavity, urine, drain swabs and
nasopharyngeal cavity).
Systematic change of tracheotomy tubes, central
catheters, urethral catheters and drains was was per-
formed. The patient also received constant antifungal
treatment with fluconazole. Antibiotic treatment and
infection monitoring was conducted in close cooperation
with the Departament of Microbiology of the Institute
of Oncology.
On the first day total gastrectomy, nutritional
treatment was introduced and continued until the return
of normal functions of alimentary tract. The supply of
proteins ranged from 1.5 to 2.0 g/kg/d (nitrogen 0.24 to
0.32 g/kg/d), the supply of calories ranged from 35 to
40 kcal/kg/d. Electrolytes, trace elements and vitamins
were also administered. Total parenteral nutrition was
administered, periodically introducing enteral nutrition
with enteral diets through a peroperatively placed
jejunostomy tube. However, due to the fistula of the small
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intestine, enteral nutrition was limited to 200 – 750
ml/day.
Lipid emulsions were administered in parenteral
nutrition as a source of calories independent of glucose,
they also provided the necessary unsaturated fatty acids
(Unsaturated fatty acids deficiency causes dermatitis,
postpones wound healing, increases platelet aggregation,
facilitates thyroid dysfunction, haemolytic anaemia and
neutropenia).
The administered lipid emulsions contained a mix-
ture of medium chain triglycerides (MCT) and long chain
triglycerides (LCT) in 50%/50% ratio. Compared with
traditional emulsions containing only LCT, MCT/LCT
mixtures undergo faster and utilisation and elimination.
They do not have such a negative impact on the immune
system, they undergo faster enzymatic hydrolysis, while
the increase in the level of fats and triglycerides in blood
serum is less frequent with MCT/LCT emulsions, as
compared to LCT-only emulsions.
After approximately 8 weeks of parenteral nutrition,
the serum level of triglycerides started to rise, and when it
exceeded the upper limit by more than 50% for three
consecutive days, the lipid emulsions were withdrawn.
After approximately 10 weeks of ICU stay incl. the
administration of broad-spectrum antibiotics and paren-
teral nutrition, Malassezia furfur was isolated from the
patient’s blood. Since, at that time, there were symptoms
of liver and kidney failure and the level of triglycerides
was still increased over the optimal level, it was decided to
exclude lipid emulsions from nutrition. This was the first
stage of treatment of the Malassezia furfur infection,
introduced before the administration of antifungal drugs
which cause kidney and liver toxicity. Lipid emulsion
withdrawal lasted for 13 days until it was confirmed that
no fungi cultures could be isolated from the patient’s
blood.,
Laboratory diagnostics
A positive culture was obtained from blood in the
BACTEC 9050 system by Becton-Dickinson on the
BACTEC Mycosis IC/F medium. Direct culture pre-
parations revealed large clusters of yeast cells, of which
only few budded (Figure 1). No fungal growth was
obtained (in the subculture from the original culture)
after 48 hours of incubation in the Sabouraud medium
(incubation at 30° C) and blood agar (37° C). It was only
after 5 days of observation that microscopic colonies
resembling bacterial colonies (Figure 2) began to grow
in the Sabouraud agar. Since the yeast cells observed in
direct culture preparations morphologically resem-
bled fungi of the Malassezia genus, at the same time
a culture was inoculated on the Sabouraud medium
supplemented with a layer of olive oil with a small
addition of Tween 80. The olive oil with Tween was
autoclaved. It was put on the surface of the agar with
a swab and meticulously spread, rubbing the fat into the
medium (1% oil can also be added to a chosen medium
before its sterilisation). In these cultures (37° C) after 48
hours, the growth of multiple colonies of yeast was
observed (Figure 3). They were identified according to the
key [4] as Malassezia furfur. The attending physician was
notified of the detection of lipophilic fungi in blood
cultures.
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Figure 1. Direct blood culture preparation in Bactec-Mycosis liquid
medium
Figure 2. Colonies cultured in the Sabouraud agar after 5 days in 30° C
/×30 magnification/
Figure 3. Culture after 48-hour incubation in 37° C in the Sabouraud
medium supplemented with olive oil
Fungus characteristics
In the media containing olive oil the fungus grows after
48 h of incubation at 32-37° C as buttery, cream or
yellowish colonies (Figure 3). In direct culture pre-
paration we can observe the presence of oval, sometimes
elongated cells, with unipolar budding, producing
no pseudohyphae (Figure 4). The fungus does not
ferment any sugars. M. furfur can also be cultured in other
media: Mycosel – Becton-Dickinson, Mycrobiotic agar –
Difco, LitmanOxgal agar – Difco with 1% addition of
olive oil.
Discussion
The presence of primary disease and the usually poor
general condition of the patient often make it difficult
to detect the etiological factor behind the infection. The
patient described here, was emaciated in the course of
the primary disease (cancer) and weakened by serious
surgical procedures, necessitating the supplementation
of parenteral nutrition with lipid substances.
Parenteral administration of lipid supplementation
creates good conditions for the growth of Malassezia furfur
inhabiting the skin. The growing number of the organisms
can initially lead to colonisation of the catheter, and then
enter blood circulation causing fungemia. The basis for
diagnosis is obtaining the growth of fungi in blood
cultures obtained from the catheter and/or cultures from
catheter tip, after its removal. In peripheral blood these
organisms are present in small amounts, which reduces
the chances of obtaining positive cultures. In the case
under discussion the fungi grew in only one culture.
Before obtaining the positive culture, two cultures had
been made with negative results. In the blood specimen
collected from the catheter one detects the presence of
small amounts of lipids, therefore the growth of fungi
from such material requires long incubation. In the case
under discussion a positive result was obtained after ten
days. For culture confirmation and identification of yeast
obtained from a liquid medium it is necessary to grow
the fungi in a solid medium. The Sabouraud agar is
routinely used for this procedure. This medium does not
contain lipid substances, so a lipophilic fungus will either
grow in such environment after a long period of
incubation or it will not grow at all. Therefore, in cases
such as this, where, despite the positive culture result and
the occurrence of fungus in direct preparation in liquid
medium, it is impossible to confirm the result and isolate
the etiological factor in solid medium by the use of
routine methods, we must consider fungi with specific
substrate requirements (lipophilia) and use a medium
supplemented with sterilised olive oil or containing oil
with Tween 80. This is especially important in cases when
an intravenous catheter is present and lipid substances
are being administered. If this is taken under account it
will significantly speed up the identification of the fungus
and increase the chances for patient survival. It is also
important to immediately remove the catheter from the
vein and perform cultures from its tip. For epidemio-
logical reasons in immunocompromised patients it is
important to pay attention to dermatitis, caused by yeast
and other fungi, which must be treated, as it may be
a potential source of infection and the cause of systemic
mycosis.
Conclusions
1. In case of fever not subsiding after antibiotic treatment
or lung trouble of unknown etiology, in emaciated
patients receiving parenteral lipid supplementation, it
is necessary to consider the possibility of fungemia
caused by lipophilic fungi (M. furfur, M. pachydermatis
or other species of this kind).
2. Detection of the occurrence of yeasts in direct
preparations of blood cultures and lack of growth in
routine media for fungus cultures indicates the
necessity to inoculate the cultures onto media
supplemented with olive oil.
3. The referral to perform a blood culture or a catheter
tip culture should contain information whether the
patient receives lipid substances in the course of
parenteral nutrition. This will aid the adequate
direction of the testing and will substantially speed up
isolation of the etiological factor and the introduction
of adequate treatment.
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Figure 4. Direct preparation after 48-hour culture in 37° C in the
Sabouraud medium supplemented with olive oil (×400 magnification)
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